Medical expert of the article
New publications
Preparations
Oseltamivir
Last reviewed: 03.07.2025

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Pharmacodynamics
The therapeutic effect of Oseltamivir is based on the suppression of enzyme activity on the surface of the influenza virus virion. In the body, the active substance of the drug oseltamivir phosphate is transformed into an active metabolite - oseltamivir carboxylate, which selectively inhibits neurominidase - a glycosidase enzyme-antigen of the cellular membranes of influenza viruses. As a result, the process of replication of viral cells and their reproduction in the affected target cells of the respiratory tract mucosa stops.
According to clinical studies, if this drug is taken within 36 hours after the onset of flu symptoms, the duration of the disease is reduced by almost 30%, and the severity of symptoms and the likelihood of complications are reduced by 40%.
Pharmacokinetics
90% of oseltamivir phosphate, absorbed in the gastrointestinal tract, is metabolized into oseltamivir carboxylate, which enters the systemic bloodstream; 3% of the substance binds to plasma proteins. Bioavailability is 75-80%.
The half-life of the drug from plasma is on average 120 minutes. Oseltamivir carboxylate is excreted from the body by the kidneys (80%) and intestines (20%); the half-life can range from 6 to 10 hours.
Dosing and administration
Oseltamivir should be taken orally (regardless of meals). For the treatment of influenza, it is recommended to take one capsule (75 mg) - twice a day; the course of treatment is 5 days. The dosage of the suspension is similar. For the prevention of influenza, take 75 mg once a day, the duration of use of the drug after contact with patients with influenza is 10 days (the preventive effect of the drug lasts only during its use).
Use Oseltamivir during pregnancy
The use of Oseltamivir during pregnancy and lactation is not recommended, since the safety of this drug for the treatment of pregnant women has not been studied.
Side effects Oseltamivir
The most common side effects of Oseltamivir are general weakness, headaches and dizziness; catarrhal phenomena (rhinorrhea, swelling of the nasal mucosa, sore throat, cough); nausea, vomiting, diarrhea, abdominal pain; sleep disorders, convulsions; allergic reactions (urticaria, bronchospasm, conjunctivitis); nosebleeds, cardiac arrhythmia, increased activity of liver enzymes. Hallucinations and mental disorders are possible.
Attention!
To simplify the perception of information, this instruction for use of the drug "Oseltamivir" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.
Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.